Bibliografia

 

Sirvent P, Mercier J, Lacampagne A. New insights into mechanism of statin-associated myitoxicity. Curr Opin Pharmacol 2008;8.333-338.

Christopher-Stine L. Statin myopathy: an update. Curr Opin Rheumatol 2006;18:647-653.

Thompson PD, Clarkson P, Karsa RH. Statin-associated myopathy.JAMA 2003;289:1681-1690.

Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidiol 2007;18:401-408.

Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am 2009;38:121-136.

Abd TT, Jacobson TA. Statin-Induced myopathy: a review and update. Expert Opin Drug Saf. 2011;10:373-387.

Kashani A, Phillips CO, Foody JM et al. Risk associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 2006;114:2788-2797.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mandami MM. Risk of incident diabetes among patients treated with statins: population based study. BMJ 2013;346:f2610doi:10.1136/bmj.f2610.

Hoffman KB, Kraus C, Dimbil M, Golomb BA. A survey of the FDA’s AERS database regarding muscle and tendon adverse events linked to statin drug class. PlosOne 2012;7:e42866.

Cornelli U, Belcaro G, Finco A. Relationship between statins adverse events and pharmacokinetic variables. In press Brit J Clin Pharmac

Li ZL, Seeram NP, Lee R et al. Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. J Altern Compl Med 2005;11:1031-1015.

Gordon RY, Becker DJ. The role of red yeast rice for the physician. Curr Atherosler Rep 2011;13:73-80.

Cesarone MR, Ledda A, Belcaro G et al. Antilip: treatment of subject with high total cholesterol tolerability and efficacy in a short term registry study. Pan Med 2010;52:15-19.

Halbert SC, French B, Gordon RY et al. Tolerability of red Yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol 2010;105:198-204.

Cornelli U. Modulatori fisiologici a presunta azione ipolipemizzante. ACSA Magazine 2010;2:1-40.

Pereira CV, Machado NG, Oliveira PJ. Mechanism of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator Tox. Sci 2008;105:408-417.